MEA DIABETES CARE DEVICES MARKET

Middle East & Africa Diabetes Care Devices Market was valued at USD 950 million in 2023 and is forecast to touch USD 1,733 million in 2031, and the market is expected to grow at a CAGR of 7.8% from 2024-2031 owing to the increasing diabetic incidence along with innovations in medical technology.

Major Drivers and Emerging Trends

The region has seen a rise in diabetic prevalence in recent years primarily driven by lifestyle changes which leads to a significant increase in primary diagnoses. According to the International Diabetes Federation in the MENA Region there are 73 million people aged between 20 and 79 living with the disease with estimates suggesting this number will rise to 95 million in 2030.

Many governments have acknowledged the crisis and are actively rolling out diverse initiatives to tackle the issue in the region. The UAE National Agenda strategies are in place to improve healthcare services and support better lifestyles. These programs aim to reduce the pressure on the healthcare system and improve the life quality for those affected by the condition.

Despite efforts to combat the disease, six countries in the region have not yet established a national action plan. Numerous countries continue to lack a national plan to tackle overweight and physical inactivity which contribute significantly to the risk of diabetes. With the majority of countries having implemented national diabetes care guidelines, the ongoing focus on reducing complications is projected to contribute to market growth.

Key industry players are concentrating on technological innovations and launching sophisticated products to secure a significant market share thereby contributing to Middle East and Africa diabetes care devices market size expansion. Technologies including CGM systems and smart insulin pens are revolutionizing diabetes management and significantly improving patient outcomes. These evolving devices are transforming care which makes disease management simpler and more effective while also increasing adoption rates across the country. These devices allow for more accurate and easier glucose monitoring along with insulin administration which leads to better patient outcomes. The smart pen combines a reusable injector with a smartphone app which provides an easy way for patients to manage their insulin delivery. It automatically calculates doses and tracks usage along with sending reminders to improve care.

Despite advancements, MEA diabetes care devices market growth is hindered by the low medical literacy and awareness in the region. Many rural areas in the region have high illiteracy rates and this gap in knowledge about medical services and their quality is restraining market growth. Widespread awareness of diabetes management devices and the disease itself is necessary to drive market growth in the region. The high cost of medical devices also continues to be a limiting factor. The economic limitations in numerous African countries make investing in these devices difficult for the population which restricts market expansion.

Type Insights: Insulin delivery devices registered the largest market size

Insulin delivery devices took the lead in the market as they are crucial to administer insulin which is a vital hormone for managing diabetes. The most prevalent devices in the market are insulin pens and pumps. There are also syringes and needles. In the MEA region, there have been notable advancements in these devices aimed at enhancing the life quality for people living with the condition. These technologies enhance the accuracy and convenience necessary for effective blood glucose management.

The blood glucose monitoring devices segment is also expanding quickly as tracking blood sugar regularly is a crucial step in managing diabetes effectively. It enables individuals to understand how various factors including diet or physical activity impact their sugar levels. This knowledge empowers them to work with their doctor to determine the most effective approach for managing their condition.

End-User Insights: Hospitals dominated the largest share

Hospitals are projected to continue leading the market driven by high patient traffic and easy access to various diabetes care devices which facilitate timely treatment. Additionally, monitoring vital signs is standard practice for hospitalized patients. Blood sugar must therefore be recognized as the essential vital metric for diabetes patients alongside temperature and blood pressure to ensure optimal care delivery.

The home care segment is also growing as more people recognize the benefits of self-managing diabetes supported by the device’s portability and advancements in technology that offer instant data for healthcare providers along with patients to make informed decisions about their treatment.

Regional Insights: Saudi Arabia holds the largest market share

Over ten percent of the population in Saudi Arabia have diabetes and the growing number is shaped by a mix of demographic and genetic influences. The increase in diabetes cases is due to factors including urbanization and reduced physical activity. The government highlighted the growing need for comprehensive healthcare services in the country triggered by an aging demographic and the increasing lifestyle diseases. Public and private sectors are actively collaborating on healthcare organizations and regulatory framework. The government is also working towards achieving full insurance coverage for all Saudi citizens as it aims to make primary healthcare affordable and accessible.

The market in South Africa is also expanding fueled by genetic factors contributing to diabetes and increasing public awareness supported by government efforts.

Top Market Players

Various key companies in the market are Abbott, Medtronic, Agamatrix, Dexcom, among others. The market in the MEA region remains fragmented as it features a combination of large and generic players with manufacturing companies continuously innovating to enhance their market position. The major companies in the market have expanded through numerous mergers and partnerships while maintaining a focus on organic growth evidenced by their increasing R&D investments.

Key Developments

• • In 2022, Abbott revealed plans to develop an innovative bio wearable device capable of continuously monitoring glucose and ketone levels with just one sensor. This innovative sensor will be connected to its digital platform including mobile apps for users and caregivers along with cloud tools for healthcare providers to conduct remote monitoring.
  • In 2022 BD and Biocorp revealed a strategic agreement to employ connected technology for monitoring the adherence of patients to self-administered treatments including biologics.
  • In 2022 Insulet Corporation known for its Omnipod tubeless insulin pumps is fostering inclusion and representation for the diabetes community using a unique activation in the Nintendo game which is Animal Crossing: New Horizons.

Segments covered in the Report:

The Middle East & Africa Diabetes Care Devices Market has been segmented on the basis of Type Outlook and End-User. Based on the Type Outlook, the market is segmented into Blood Glucose Monitoring Devices and Insulin Delivery Devices. The Blood Glucose Monitoring Devices segment is further segmented into Self-monitoring Devices (Blood Glucose Meters, Testing Strips, Lancets) and Continuous Glucose Monitoring Devices (Sensors, Transmitters, Receiver). The Insulin Delivery Devices segment is further segmented into Insulin Pumps, Insulin Pens, Insulin Syringes. Based on the end-user, the market is segmented into Hospitals, Homecare Setting, Others.

Report Coverage	Details
Market Revenues (2023)	USD Million
Market Base Year	2023
Market Forecast Period	2024-2031
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Type Outlook, By End-User
Regional Coverage	Middle East & Africa
Companies Profiled	Abbott, Medtronic, Agamatrix, Dexcom, among others; a total of 4 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Market Segmentation

Middle East & Africa Diabetes Care Devices Market by Type Outlook

• • Blood Glucose Monitoring Devices
    • Self-monitoring Devices
      • Blood Glucose Meters
      • Testing Strips
      • Lancets
    • Continuous Glucose Monitoring Devices
      • Sensors
      • Transmitters
      • Receiver
  • Insulin Delivery Devices
    • Insulin Pumps
    • Insulin Pens
    • Insulin Syringes

Middle East & Africa Diabetes Care Devices Market by End-User

• • Hospitals
  • Homecare Setting
  • Others

Middle East & Africa Diabetes Care Devices Market by Countries

• • UAE Diabetes Care Devices Market All-Up (Option 1: As a part of the free 25% customization)
  • Turkey Diabetes Care Devices Market All-Up (Option 2: As a part of the free 25% customization)
  • Egypt Diabetes Care Devices Market All-Up (Option 3: As a part of the free 25% customization)
  • Saudi Arabia Diabetes Care Devices Market All-Up (Option 4: As a part of the free 25% customization)
  • Rest of MEA Diabetes Care Devices Market All-Up (Option 5: As a part of the free 25% customization)

Middle East & Africa Diabetes Care Devices Market Leading players (Option 1: Free 25% Customization – Profiles of 5 Additional Companies of your Choice)

• • Abbott
  • Medtronic
  • Agamatrix
  • Dexcom